Improved Exercise Capacity and Ischemia 6 and 12 Months After Transendocardial Injection of Autologous Bone Marrow Mononuclear Cells for Ischemic Cardiomyopathy - Concepedia

Concepedia

Publication | Closed Access

Improved Exercise Capacity and Ischemia 6 and 12 Months After Transendocardial Injection of Autologous Bone Marrow Mononuclear Cells for Ischemic Cardiomyopathy

356

Citations

20

References

2004

Year

Emerson C. Perin, Hans Fernando Rocha Dohmann, Radovan Borojević, Suzana A. Silva, A Sousa, Guilherme V. Silva, Cláudio Tinoco Mesquita, Luciano Herman Juaçaba Belém, William K. Vaughn, Fernando Oswaldo Dias Rangel,

Abstract

The 6- and 12-month follow-up data in this study suggest that transendocardial injection of ABMMNCs in patients with end-stage ischemic heart disease may produce a durable therapeutic effect and improve myocardial perfusion and exercise capacity.

References

	Year	Citations

Page 1